Companies / Creative Biolabs / Anti-PDCD1 Recombinant Antibody (Nivolumab)
Creative Biolabs

Anti-PDCD1 Recombinant Antibody (Nivolumab) | Creative Biolabs

Recombinant human monoclonal antibody expressed in CHO binding to human PDCD1. Nivolumab is a fully human IgG4 monoclonal antibody for the treatment of cancer. Nivolumab acts as an immunomodulator by blocking ligand activation of the programmed cell death 1 (PD-1) receptor on activated T cells.

Supporting Documents


Data Sheet

Datasheet

MSDS

MSDS

Reviews


No reviews yet

ABOUT THE COMPANY

Creative Biolabs is the leading custom service provider with extensive experience in various antibody production and engineering fields.